Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial.

Chawla, Bharat

Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial. [electronic resource] - Human psychopharmacology Apr 2008 - 211-6 p. digital

Publication Type: Clinical Trial; Journal Article

1099-1077

10.1002/hup.921 doi


Adult
Antipsychotic Agents--administration & dosage
Benzodiazepines--administration & dosage
Body Mass Index
Chemistry, Pharmaceutical
Chronic Disease
Dose-Response Relationship, Drug
Female
Humans
Male
Olanzapine
Overweight--complications
Prospective Studies
Psychotic Disorders--complications
Schizophrenia--complications
Weight Loss--drug effects